Rapporto sulle dimensioni del mercato del trattamento delle infezioni del tratto urinario e sull’analisi delle quote | Previsioni 2031

  • Report Code : TIPRE00005931
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 241
Buy Now

[Rapporto di ricerca] Si prevede che il mercato raggiungerà 11.614,32 milioni di dollari entro il 2027 rispetto a 9.106,40 milioni di dollari nel 2019; si stima che crescerà a un CAGR del 3,2% dal 2020 al 2027.

La crescita del mercato è attribuita alla crescente prevalenza di infezioni del tratto urinario e all'invecchiamento della popolazione e tecnologie informatiche emergenti per la diagnostica delle urine. Tuttavia, la mancanza di consapevolezza del prodotto nei paesi emergenti e gli effetti associati ai farmaci ostacolano in una certa misura la crescita del mercato del trattamento delle infezioni del tratto urinario.

Mercati regionali redditizi per Trattamento delle infezioni del tratto urinario


Approfondimenti di mercato


Crescente incidenza delle infezioni del tratto urinario

Le donne corrono un rischio maggiore di sviluppare infezioni del tratto urinario (UTI) rispetto agli uomini. Le infezioni del tratto urinario, se non trattate, possono causare forti dolori e gravi conseguenze ai reni. Le infezioni delle vie urinarie mostrano alcuni sintomi come il bisogno persistente di urinare, infiammazione, cambiamento nell'aspetto delle urine e nausea. La crescente prevalenza delle infezioni del tratto urinario è uno dei fattori importanti che guidano la crescita del mercato del trattamento delle infezioni del tratto urinario. Ad esempio, secondo uno studio condotto da un gruppo di ricercatori dell’American College of Physicians and Infectious Diseases Society of America nel 2020, le infezioni del tratto urinario rappresentano circa 6 milioni di visite mediche ogni anno negli Stati Uniti.

Alcuni fattori di rischio come l'attività sessuale, la scarsa igiene e l'invecchiamento possono causare infezioni del tratto urinario. Si stima inoltre che la crescente incidenza di questi fattori di rischio guiderà la crescita del mercato del trattamento delle infezioni del tratto urinario entro il 2027. Secondo uno studio pubblicato sull'International Journal of Environmental Research and Public Health nel 2019, i pazienti con patologie croniche esistenti come la malattia coronarica ( CAD), malattia renale cronica (CKD) e diabete mellito (DM) hanno elevate probabilità di contrarre infezioni del tratto urinario. Pertanto, l'elevata epidemiologia delle infezioni delle vie urinarie genera domanda per i suoi prodotti terapeutici, guidando infine la crescita del mercato.

Approfondimenti basati sulla classe di farmaci

Basato su classe dei farmaci, il segmento dei chinoloni ha detenuto la quota maggiore del mercato nel 2019; tuttavia, si prevede che il segmento della penicillina e delle combinazioni registrerà il CAGR più elevato, pari al 4,5%, nel mercato durante il periodo di previsione. La futura crescita del mercato dei chinoloni è da attribuire soprattutto al fatto che vengono prescritti soprattutto dai medici. Ciprofloxacina, levofloxacina ed enoxacina sono tra i farmaci più utilizzati per il trattamento.

Mercato del trattamento delle infezioni del tratto urinario, per classe di farmaci: 2019 e 2027


Approfondimenti basati sulle indicazioni

Il mercato del trattamento delle infezioni del tratto urinario, per indicazione, è segmentato in infezioni complicate delle vie urinarie e infezioni non complicate delle vie urinarie. Il segmento delle infezioni complicate del tratto urinario ha detenuto una quota di mercato maggiore nel 2019; inoltre, si prevede che il segmento registrerà un CAGR più elevato nel mercato durante il periodo di previsione.

Approfondimenti basati sui canali di distribuzione

Il tratto urinario Il mercato del trattamento delle infezioni, per canale di distribuzione, è segmentato in farmacie ospedaliere, cliniche di ginecologia e urologia, farmacie, farmacie al dettaglio e farmacie online. Il segmento del canale di distribuzione delle farmacie ospedaliere ha detenuto la quota maggiore del mercato nel 2019, mentre si prevede che il segmento delle farmacie online registrerà il CAGR più elevato del mercato durante il periodo di previsione.

< h3>Approfondimenti strategici

Gli attori del mercato del trattamento delle infezioni del tratto urinario, come Shionogi & Co., Ltd.; Teva Industrie Farmaceutiche Ltd;  Allergan; e Pfizer hanno adottato diverse strategie organiche e inorganiche per migliorare le proprie entrate e la propria posizione di mercato. Ad esempio, nell'aprile 2019, Teva Pharmaceutical Industries Ltd ha annunciato il lancio di una versione generica delle compresse VESIcare (solifenacina succinato), da 5 mg e 10 mg, negli Stati Uniti.

< h3>Mercato del trattamento delle infezioni del tratto urinario: per classe di farmaco
  • Penicillina e combinazioni
  • Chinoloni
  • Cefalosporina
  • Antibiotici aminoglicosidici
  • Sulfamidici< /li>
  • Integratori nutrizionali


Mercato del trattamento delle infezioni del tratto urinario– per indicazione

  • Infezioni complicate delle vie urinarie
  • Infezioni non complicate delle vie urinarie


Mercato del trattamento delle infezioni delle vie urinarie– per canale di distribuzione

  • Farmacie ospedaliere
  • Cliniche di ginecologia e urologia
  • Farmacie al dettaglio e parafarmacie
  • Negozi di farmaci online


Mercato del trattamento delle infezioni del tratto urinario - per area geografica

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • < li>Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto dell'Europa
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
    • Resto dell'Asia Pacifico
  • Medio Oriente e Africa (MEA)
    • Sudafrica
    • Arabia Saudita
    • Emirati Arabi Uniti
    • Resto del Medio Oriente e dell'Africa
  • Sud e America Centrale
    • Brasile
    • Argentina
    • Resto dell'America Centrale e Meridionale

Profili aziendali

  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Mylan NV
  • < li>ALLERGAN
  • Pfizer Inc.
  • Cipla Ltd
  • F. Hoffmann-La Roche Ltd
  • Shionogi Inc.
  • Amway
  • DuPont Nutrition & Bioscienze
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies - Urinary Tract Infection Treatment Market

 

  1. Teva Pharmaceutical Industries Ltd
  2. Sun Pharmaceutical Industries Ltd
  3. Mylan N.V.
  4. ALLERGAN
  5. Pfizer Inc.
  6. Cipla Ltd
  7. F. Hoffmann-La Roche Ltd
  8. Shionogi Inc.
  9. Amway
  10. DuPont Nutrition & Biosciences

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports